This session will outline the challenges faced by community-based oncologists and pathologists in practicing precision medicine. Focusing on biomarker delivery in lung cancer, the talk will outline difficulties, essential components, and keys for success, in delivering these results so as to maximize their clinical utility. Finally, we will explore some additional benefits that rapidly-delivered NGS can bring to a clinical practice.
1. Be able to outline key lung cancer biomarkers associated with patient care
2. Have in-depth understanding of the obstacles of single-gene testing for diagnosis